Impaired nerve fiber regeneration in axotomized peripheral nerves in streptozotocin-diabetic rats

Journal of Diabetes Investigation

Volumn 4, Issue 6, 2013, Pages 533-539

  Nishida, Naoki ^a,b   Yamagishi, Shin Ichiro ^a   Mizukami, Hiroki ^a   Yagihashi, Soroku ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Fiber atrophy; Myelination; Nerve regeneration

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; IMPAIRED NERVE FIBER REGENERATION; MALE; MORPHOMETRICS; MYELINATED NERVE; NERVE FIBER REGENERATION; NERVE FIBER TRANSECTION; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

EID: 84888439219     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12115     Document Type: Article

References (35)

1. Vinik AI, Newlon POG, Lauterio TJ, et al. Nerve survival and regeneration in diabetes. Diabetes Rev 1996; 3: 139-157.
2. Dyck PJ, Giannini C. Pathologic alterations in the diabetic neuropathies of humans. J Neuropathol Exp Neurol 1996; 55: 1181-1193.
3. Longo FM, Powell HC, LeBeau J, et al. Delayed nerve regeneration in streptozotocin diabetic rats. Muscle Nerve 1986; 9: 385-393.
4. Calcutt NA, Mizicin AP, Yaksh TL. Impaired induction of vasoactive intestinal polypeptide after sciatic nerve injury in the streptozotocin-diabetic rat. J Neurol Sci 1993; 119: 154-161.
5. Pekiner C, Dent EW, Roberts RE, et al. Altered GAP-43 immunoreactivity in regenerating sciatic nerve of diabetic rats. Diabetes 1996; 45: 199-204.
6. Ekström PAR, Tomlinson DR. Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor. J Neurol Sci 1989; 93: 231-237.
7. Calcutt NA, McMurray HF, Moorhouse DF. Inhibition of macrophage chemotaxis and peripheral nerve regeneration in normal and hyperglycemic rats by the aldose reductase inhibitor tolrestat. Exp Neurol 1994; 128: 226-232.
8. Terada M, Yasuda H, Kikkawa R, et al. Tolrestat improves nerve regeneration after crush injury in streptozocin-induced diabetic rats. Metabolism 1996; 45: 1189-1195.
9. Kamijo M, Merry AC, Akdas G, et al. Nerve fiber regeneration following axotomy in the diabetic biobreeding Worcester rat: the effect of ARI treatment. J Diabetes Complications 1996; 10: 183-191.
10. Federoff HJ, Lawrence D, Brownlee M. Nonenzymatic glycosylation of laminin and the laminin peptide CIKVAVS inhibits neurite outgrowth. Diabetes 1993; 42: 509-513.
11. Love A, Cotter MA, Cameron NE. Effects of the sulphydryl donor N-acetyl-l-cysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats. Eur J Clin Invest 1996; 26: 698-706.
12. Cameron NE, Cotter MA. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res Clin Pract 1999; 45: 137-146.
13. Greene DA, Arezzo JC, Brown MB, et al. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Neurology 1999; 53: 580-591.
14. Apfel SC. Neurotrophic factors in peripheral neuropathies: therapeutic implications. Brain Pathol 1999; 9: 393-413.
15. Tomlinson DR, Fernyhough P, Diemel LT. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes 1997; 46(Suppl. 2): S43-S49.
16. Sharma AK, Thomas PK. Peripheral nerve regeneration in experimental diabetes. J Neurol Sci 1975; 24: 417-424.
17. Terada M, Yasuda H, Kikkawa R. Delayed Wallerian degeneration and increased neurofilament phosphorylation in sciatic nerves of rats with streptozocin-induced diabetes. J Neurol Sci 1998; 155: 23-30.
18. Yagihashi S, Kamijo M, Watanabe K. Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rat. Am J Pathol 1990; 136: 1365-1373.
19. Yagihashi S, Wada R, Kamijo M, et al. Peripheral neuropathy in the WBN/Kob rat with chronic panreatitis and spontaneous diabetes. Lab Invest 1993; 68: 296-307.
20. Dyck PJ, Lambert EH, Windebank AJ, et al. Acute hyperosmolar hyperglycemia causes axonal shrinkage and reduced nerve conduction velocity. Exp Neurol 1981; 71: 507-514.
21. Dyck PJ, Lais AC, Karnes J, et al. Peripheral axotomy induces neurofilament decrease, atrophy, demyelination and degeneration of root and fasciculus gracilis fibers. Brain Res 1985; 340: 19-36.
22. Thomas PK, Fraher JP, O'Leary D, et al. Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat. 2. Effect of streptozotocin-induced diabetes. Acta Neuropathol 1990; 79: 375-386.
23. Hoffman PN, Cleveland DW, Griffin JW, et al. Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci USA 1987; 84: 3472-3476.
24. Hoffman PN, Griffin JW, Price DL. Control of axonal caliber by neurofilament transport. J Cell Biol 1990; 99: 1365-1373.
25. Medori R, Autilio-Gambetti L, Monaco S, et al. Experimental diabetic neuropathy: impairment of slow axonal transport with changes in axon cross-sectional area. Proc Natl Acad Sci USA 1985; 82: 7716-7720.
26. Medori R, Autilio-Gambetti L, Jenich H, et al. Changes in axon size and slow axonal transport are related in experimental diabetic neuropathy. Neurology 1988; 38: 597-601.
27. Powell HC, Longo FM, LeBeau JM, et al. Abnormal nerve regeneration in galactose neuropathy. J Neuropath Exp Neurol 1986; 45: 151-160.
28. Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987; 316: 599-606.
29. Kirscher DA, Eichberg J. Restricted hypotonic swelling of peripheral nerve myelin in streptozocin-induced diabetic rats. J Neurosci Res 1994; 38: 142-148.
30. Boyles JK, Notterpek LM, Anderson CJ. Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E and apolipoprotein A-I. J Biol Chem 1990; 265: 17805-17815.
31. Jaffey PB, Gelman BB. Increased vulnerability to demyelination in streptozotocin diabetic rats. J Comp Neurol 1996; 373: 55-61.
32. Maxfield EK, Love A, Cotter MA, et al. Nerve function and regeneration in diabetic rats: effects of ZD-7155, an AT1 receptor antagonist. Am J Physiol 1995; 269: E530-E537.
33. Dyck PJ, Karnes JL, Daube J, et al. Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 1985; 108: 861-880.
34. Britland ST, Young RJ, Sharma AK, et al. Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes 1990; 39: 898-908.
35. Zochodne ZW. The microenvironment of injured and regenerating peripheral nerves. Muscle Nerve 2000; 9(Suppl.): S33-S38.